FDA accepts Eliquis® (apixaban) sNDA for review for prophylaxis of deep vein thrombosis following hip or knee replacement surgery
11 July 2013 | By Bristol-Myers Squibb Company
FDA accepted for review a sNDA for Eliquis®
List view / Grid view
News
Catalent and Biota Pharmaceuticals expand their alliance
10 July 2013 | By Catalent Pharma Solutions
Catalent Pharma Solutions has entered into a contract with Biota Pharmaceuticals, Inc...
Boehringer Ingelheim and Ashoka Changemakers announce winners of Transforming Health Systems competition
10 July 2013 | By Boehringer Ingelheim
“We were thrilled by the level of innovation...”
Roche halts investigation of aleglitazar following regular safety review of phase III trial
10 July 2013 | By Roche
"The safety of patients is our first priority..."
Pfizer receives european approval to expand use of Prevenar 13* to adults aged 18 to 49 years for the prevention of invasive Pneumococcal Disease
10 July 2013 | By Pfizer
Prevenar 13* received European approval...
Abbott announces approval of next-generation XIENCE Xpedition™ drug Eluting Stent System in Japan
10 July 2013 | By Abbott
Enhanced deliverability with new stent delivery system...
GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
9 July 2013 | By GlaxoSmithKline
GSK announced submission of NDAs to the US FDA for use of dabrafenib...
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
9 July 2013 | By AstraZeneca
AstraZeneca enters agreement with University of Cambridge & Cancer Research UK...
Amgen and Servier announce product collaboration
9 July 2013 | By Amgen
Amgen obtains US rights to novel EU-approved cardiovascular therapy; Servier receives option for omecamtiv mecarbil in Europe...
Sanofi Patient Group Bursary winners announced
8 July 2013 | By Just:: Health PR
Sanofi is delighted to announce the winners of its 2013 Patient Group Bursary scheme...
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
8 July 2013 | By Boehringer Ingelheim
EMA accepted companies' MAA...
Novartis announces secukinumab (AIN457) demonstrated superiority to Enbrel® in head-to-head Phase III psoriasis study
8 July 2013 | By Novartis
All primary & secondary endpoints were met...
Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world
8 July 2013 | By Novartis
Novartis has entered into a development and licensing agreement with Biological E Limited...
Student becomes first recipient of unique Strathclyde degree with GSK
4 July 2013 | By GlaxoSmithKline
A student has become the first to graduate from a landmark research programme run by the University of Strathclyde...
FDA grants Roche’s obinutuzumab (GA101) Priority Review for previously untreated chronic lymphocytic leukemia
3 July 2013 | By Roche
FDA decision on the GA101 BLA is expected by the end of 2013...
